156 related articles for article (PubMed ID: 33429741)
1. Comparison of the efficacy of rivaroxaban and dabigatran etexilate in preventing venous thrombosis after arthroplasty: A protocol of randomized controlled trial.
Song R; Qu R; Wang Y; Zhou D; Zhang A
Medicine (Baltimore); 2021 Jan; 100(1):e23814. PubMed ID: 33429741
[TBL] [Abstract][Full Text] [Related]
2. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.
Khorana AA; Noble S; Lee AYY; Soff G; Meyer G; O'Connell C; Carrier M
J Thromb Haemost; 2018 Sep; 16(9):1891-1894. PubMed ID: 30027649
[No Abstract] [Full Text] [Related]
3. A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery.
Mayer A; Schuster P; Fink B
Arch Orthop Trauma Surg; 2017 Jun; 137(6):797-803. PubMed ID: 28439702
[TBL] [Abstract][Full Text] [Related]
4. Direct oral anticoagulants: An update.
Franco Moreno AI; Martín Díaz RM; García Navarro MJ
Med Clin (Barc); 2018 Sep; 151(5):198-206. PubMed ID: 29295790
[TBL] [Abstract][Full Text] [Related]
5. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
Lin C; Quan J; Bao Y; Hua W; Ke M; Zhang N; Jin Q; Xie Y; Wei Y; Ling T; Pan W; Wu L; Xie Y
J Cardiovasc Electrophysiol; 2020 Mar; 31(3):658-663. PubMed ID: 31975470
[TBL] [Abstract][Full Text] [Related]
6. Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
Loke YK; Kwok CS
J Clin Pharm Ther; 2011 Feb; 36(1):111-24. PubMed ID: 21198726
[TBL] [Abstract][Full Text] [Related]
7. Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement.
Özler T; Uluçay Ç; Önal A; Altıntaş F
Acta Orthop Traumatol Turc; 2015; 49(3):255-9. PubMed ID: 26200403
[TBL] [Abstract][Full Text] [Related]
8. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
[TBL] [Abstract][Full Text] [Related]
9. [Not Available].
Själander S; Själander A
Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512136
[No Abstract] [Full Text] [Related]
10. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
[TBL] [Abstract][Full Text] [Related]
11. Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.
Senay A; Trottier M; Delisle J; Banica A; Benoit B; Laflamme GY; Malo M; Nguyen H; Ranger P; Fernandes JC
Vasc Health Risk Manag; 2018; 14():81-89. PubMed ID: 29780248
[TBL] [Abstract][Full Text] [Related]
12. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
Suen K; Westh RN; Churilov L; Hardidge AJ
J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
[TBL] [Abstract][Full Text] [Related]
13. Nonvitamin K Antagonist Oral Anticoagulant in Patients With Venous Thromboembolism and Polycythemia Vera or Essential Thrombocythemia: A Cohort Study.
Weronska A; Papuga-Szela E; Broniatowska E; Undas A
J Cardiovasc Pharmacol; 2021 Nov; 78(5):e743-e748. PubMed ID: 34321399
[TBL] [Abstract][Full Text] [Related]
14. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
Squizzato A; Lussana F; Cattaneo M
Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants.
Wolfe Z; Khan SU; Nasir F; Raghu Subramanian C; Lash B
J Thromb Haemost; 2018 Jul; 16(7):1296-1306. PubMed ID: 29723935
[TBL] [Abstract][Full Text] [Related]
16. Safety of dabigatran or rivaroxaban for thoracoscopic ablation in patients with atrial fibrillation.
Im SI; Jeong DS; Park SJ; Park KM; Huh J; Kim JS; On YK
Int J Cardiol; 2015; 186():213-5. PubMed ID: 25828118
[No Abstract] [Full Text] [Related]
17. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
Eriksson BI; Dahl OE; Rosencher N; Kurth AA; van Dijk CN; Frostick SP; Kälebo P; Christiansen AV; Hantel S; Hettiarachchi R; Schnee J; Büller HR;
J Thromb Haemost; 2007 Nov; 5(11):2178-85. PubMed ID: 17764540
[TBL] [Abstract][Full Text] [Related]
18. Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.
Halton JML; Albisetti M; Biss B; Bomgaars L; Brueckmann M; Gropper S; Harper R; Huang F; Luciani M; Maas H; Tartakovsky I; Mitchell LG
J Thromb Haemost; 2017 Nov; 15(11):2147-2157. PubMed ID: 28921890
[TBL] [Abstract][Full Text] [Related]
19. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis.
Robertson L; Kesteven P; McCaslin JE
Cochrane Database Syst Rev; 2015 Jun; (6):CD010956. PubMed ID: 26123214
[TBL] [Abstract][Full Text] [Related]
20. Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.
Gao JH; Chu XC; Wang LL; Ning B; Zhao CX
Medicine (Baltimore); 2017 Oct; 96(40):e8059. PubMed ID: 28984761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
